{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:03:32Z","timestamp":1771427012336,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pharma.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:49:38Z","timestamp":1758055778000},"page":"201-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of metabolic syndrome on health-related quality of life and its determinants in post-myocardial infarction patients"],"prefix":"10.1016","volume":"84","author":[{"given":"Anam Anwar","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejashree","family":"Padmanabha Hola.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Treesa P.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2025.09.003_bib0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1755-5922.12233","article-title":"Platelet activating factor: a potential biomarker in acute coronary syndrome?","volume":"35","author":"Palur Ramakrishnan","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.pharma.2025.09.003_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1573403X15666191127104520","article-title":"Depression related pathophysiologies relevant in heart disease: insights into the mechanism based on pharmacological treatments","volume":"16","author":"Varghese","year":"2020","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare","year":"2024","journal-title":"Glob Heart"},{"key":"10.1016\/j.pharma.2025.09.003_bib0195","doi-asserted-by":"crossref","first-page":"6894693","DOI":"10.1155\/2024\/6894693","article-title":"Cardiovascular diseases among Indian older adults: a comprehensive review","volume":"2024","author":"Jan","year":"2024","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.pharma.2025.09.003_bib0200","first-page":"1935","article-title":"Link between metabolic syndrome and diabetes mellitus: a pathophysiological implication","volume":"11","author":"James","year":"2019","journal-title":"Int J Sci Technol Res"},{"key":"10.1016\/j.pharma.2025.09.003_bib0205","first-page":"22","article-title":"Quality of life and depression assessment in patients with acute coronary syndrome: a cross-sectional study","author":"Varghese","year":"2022","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.pharma.2025.09.003_bib0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.12980\/jclm.4.2016J6-102","article-title":"Assessment of diabetes related quality of life and the impact of pharmaceutical care in its improvement","volume":"4","author":"Faizal","year":"2016","journal-title":"J Coastal Life Med"},{"issue":"16","key":"10.1016\/j.pharma.2025.09.003_bib0215","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","article-title":"Cardiovascular diseases in India: current epidemiology and future directions","volume":"133","author":"Prabhakaran","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pharma.2025.09.003_bib0220","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1186\/s12889-019-7623-2","article-title":"Quality of life assessment in patients with heart failure: validity of the German version of the generic EQ-5D-5L","volume":"19","author":"Boczor","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pharma.2025.09.003_bib0225","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"key":"10.1016\/j.pharma.2025.09.003_bib0235","series-title":"Methods for analysing and reporting EQ-5D data","author":"Devlin","year":"2020"},{"key":"10.1016\/j.pharma.2025.09.003_bib0240","doi-asserted-by":"crossref","first-page":"e039517","DOI":"10.1136\/bmjopen-2020-039517","article-title":"Valuing health-related quality of life among the Indian population: a protocol for the development of an EQ-5D value set for India using an extended design (DEVINE) study","volume":"10","author":"Jyani","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharma.2025.09.003_bib0245","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jval.2021.11.1370","article-title":"Development of an EQ-5D value set for India using an extended design (DEVINE) study: the Indian 5-level version EQ-5D value set","volume":"25","author":"Jyani","year":"2022","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.pharma.2025.09.003_bib0250","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s11136-025-03947-6","article-title":"Exploring the origin and conceptual framework of the EQ VAS","volume":"34","author":"Chuang","year":"2025","journal-title":"Qual Life Res"},{"issue":"Suppl. 1","key":"10.1016\/j.pharma.2025.09.003_bib0255","first-page":"2","article-title":"The National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"9","author":"Lipsy","year":"2003","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mjafi.2019.12.001","article-title":"Metabolic syndrome: the Indian public health perspective","volume":"76","author":"Bhalwar","year":"2020","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0265","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12872-025-04684-x","article-title":"Impact of metabolic syndrome on clinical characteristics and one-year outcomes of patients undergoing primary percutaneous coronary intervention: a propensity score-matched comparison","volume":"25","author":"Geraiely","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"10.1016\/j.pharma.2025.09.003_bib0270","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1751-7176.2010.00371.x","article-title":"Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six middle eastern countries","volume":"12","author":"Al Suwaidi","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.pharma.2025.09.003_bib0275","doi-asserted-by":"crossref","first-page":"101341","DOI":"10.1016\/j.cegh.2023.101341","article-title":"Assessment of metabolic syndrome and its components in patients with acute coronary syndrome","volume":"22","author":"Varghese","year":"2023","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.pharma.2025.09.003_bib0280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40200-020-00523-2","article-title":"Association between metabolic syndrome and diabetes mellitus according to International Diabetic Federation and National Cholesterol Education Program Adult Treatment Panel III criteria: a cross-sectional study","volume":"19","author":"James","year":"2020","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.18203\/2349-3933.ijam20195664","article-title":"Prevalence of metabolic syndrome and its different components in patients with acute coronary syndrome","volume":"7","author":"Jain","year":"2019","journal-title":"Int J Adv Med"},{"issue":"7","key":"10.1016\/j.pharma.2025.09.003_bib0290","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5539\/gjhs.v6n7p58","article-title":"Survey of the relationship between metabolic syndrome and myocardial infarction in hospitals of Urmia University of Medical Sciences","volume":"6","author":"Khademvatan","year":"2014","journal-title":"Glob J Health Sci"},{"issue":"5","key":"10.1016\/j.pharma.2025.09.003_bib0295","first-page":"1999","article-title":"Predisposing risk factors of acute coronary syndrome (ACS): a mini review","volume":"11","author":"Varghese","year":"2019","journal-title":"J Pharm Sci Res"},{"issue":"4","key":"10.1016\/j.pharma.2025.09.003_bib0300","first-page":"504","article-title":"Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity","volume":"11","author":"Henning","year":"2021","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.pharma.2025.09.003_bib0305","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharma.2025.09.003_bib0310","first-page":"12756","article-title":"How healthy are health professionals? Health related quality of life of doctors and paramedics at a tertiary care hospital in India","volume":"4","author":"Patel","year":"2016","journal-title":"JMSCR"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0315","doi-asserted-by":"crossref","first-page":"e10178","DOI":"10.2196\/10178","article-title":"EuroQol (EQ-5D-5L) validity in assessing the quality of life in adults with asthma: cross-sectional study","volume":"21","author":"Hernandez","year":"2019","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.pharma.2025.09.003_bib0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.pharma.2025.09.003_bib0325","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5114\/aoms\/157308","article-title":"Menopause and women's cardiovascular health: is it really an obvious relationship?","volume":"19","author":"Ryczkowska","year":"2022","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.pharma.2025.09.003_bib0330","doi-asserted-by":"crossref","first-page":"1085950","DOI":"10.3389\/fendo.2023.1085950","article-title":"Understanding the relationships between physiological and psychosocial stress, cortisol and cognition","volume":"14","author":"James","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.pharma.2025.09.003_bib0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1573403X15666191127104520","article-title":"Depression related pathophysiologies relevant in heart disease: insights into the mechanism based on pharmacological treatments","volume":"16","author":"Varghese","year":"2020","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0340","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12955-021-01861-2","article-title":"Health-related quality of life in men and women who experienced cardiovascular diseases: Tehran Lipid and Glucose Study","volume":"19","author":"Jalali-Farahani","year":"2021","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.pharma.2025.09.003_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-020-01433-w","article-title":"Quality of life among patients with cardiac disease: the impact of comorbid depression","volume":"18","author":"Bahall","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"10.1016\/j.pharma.2025.09.003_bib0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.repc.2019.09.013","article-title":"Quality of life in adults living in the community with previous self-reported myocardial infarction","volume":"39","author":"Tim\u00f3teo","year":"2020","journal-title":"Rev Port Cardiol"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925001439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:05:01Z","timestamp":1771423501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925001439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0003450925001439"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.09.003","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of metabolic syndrome on health-related quality of life and its determinants in post-myocardial infarction patients","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}